| Assay ID | Title | Year | Journal | Article |
|---|
| AID240866 | Inhibitory concentration against the Flap endonuclease-1 | 2005 | Bioorganic & medicinal chemistry letters, Jan-17, Volume: 15, Issue:2
| The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. |
| AID1446103 | Inhibition of recombinant human carbonic anhydrase 9 preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay | 2017 | Journal of medicinal chemistry, 07-27, Volume: 60, Issue:14
| 3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII. |
| AID1446105 | Inhibition of recombinant human carbonic anhydrase 1 preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay | 2017 | Journal of medicinal chemistry, 07-27, Volume: 60, Issue:14
| 3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII. |
| AID431469 | Antiviral activity against HIV infected in human MT4 cells up to 100 uM by multicycle infectivity assay | 2009 | Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
| RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. |
| AID431468 | Inhibition of HIV1 recombinant reverse transcriptase p66/p51 heterodimer in presence of Mg2+ | 2009 | Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
| RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. |
| AID1446104 | Inhibition of recombinant human carbonic anhydrase 12 preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay | 2017 | Journal of medicinal chemistry, 07-27, Volume: 60, Issue:14
| 3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII. |
| AID241035 | Inhibitory concentration against the xeroderma pigmentosum G | 2005 | Bioorganic & medicinal chemistry letters, Jan-17, Volume: 15, Issue:2
| The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. |
| AID1247800 | Inhibition of DNAse1 (unknown origin) | 2015 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
| N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF. |
| AID1446106 | Inhibition of recombinant human carbonic anhydrase 2 preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay | 2017 | Journal of medicinal chemistry, 07-27, Volume: 60, Issue:14
| 3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII. |
| AID431467 | Inhibition of human RNase H assessed as substrate cleavage by fluorescence assay | 2009 | Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
| RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. |
| AID1247798 | Inhibition of ERCC1-XPF (unknown origin) by high-throughput fluorescence based in-vitro endonuclease assay | 2015 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
| N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF. |
| AID1247799 | Inhibition of FEN1 (unknown origin) | 2015 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
| N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF. |
| AID1799248 | Fluorescence-Based RNase H Assay from Article 10.1021/jm900597q: \\RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.\\ | 2009 | Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
| RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |